Uncertainty Propagation for Echocardiography Clinical Metric Estimation via Contour Sampling

summary

Video file (mp4)

The gist

The gist: This work proposes a novel uncertainty estimation method based on contouring rather than segmentation to propagate uncertainty from input images to derived clinical metrics in

In short

The work proposes a novel uncertainty estimation method based on contouring instead of pixel-wise segmentation for echocardiography. It models uncertainty by predicting contour location uncertainty and then sampling contours to propagate this uncertainty to derived clinical metrics like ejection fraction. This approach combines aleatoric and epistemic uncertainties effectively.

Key concepts

Contour-based Aleatoric Uncertainty Modeling
Instead of measuring pixel-level uncertainty, this method models the uncertainty of where the contour points are located. A neural network predicts heatmaps showing both the center (mean position) and a halo (uncertainty size) for each potential point on the contour.
Shape Uncertainty Modeling (PSM)
To handle multiple contours needed for clinical metrics, a Posterior Shape Model based on Principal Component Analysis (PCA) is used. This statistical model predicts the uncertainty of one point given the positions of other points, allowing for more accurate shape modeling than simple independent sampling.
Aleatoric and Shape Uncertainty Fusion
A hierarchical sampling algorithm combines contour uncertainty and shape uncertainty. It samples basal and apex points first, uses the shape model to predict conditional distributions, and then fuses these distributions to generate new conditioned distributions for all points.

Terminology used across episodes

This episode discusses

The paper

Uncertainty Propagation for Echocardiography Clinical Metric Estimation via Contour Sampling · Read on arXiv

Thierry Judge, Olivier Bernard, Woo-Jin Cho Kim, Alberto Gomez, Arian Beqiri, Agisilaos Chartsias

University of Sherbrooke Department of Computer Science University of Sherbrooke INSA Universite Claude Bernard Lyon 1 CNRS UMR 5220 Inserm U1206 CREATIS Ultromics Ltd. King’s College London

Echocardiography plays a fundamental role in the extraction of clinical parameters (e.g. left ventricular volume and ejection fraction) required to determine the presence and severity of heart-related conditions. When deploying automated techniques for computing these parameters, uncertainty estimation is highly valuable for assessing their utility. Since clinical parameters are usually derived from segmentation maps, there is no clear path for converting pixel-wise uncertainty values into uncertainty estimates in the downstream clinical metric calculation. In this work, we propose a novel uncertainty estimation method based on contouring rather than segmentation. Our method explicitly predicts contour location uncertainty from which contour samples can be drawn. Finally, the sampled contours can be used to propagate uncertainty to clinical metrics. Our proposed method not only provides accurate uncertainty estimations for the task of contouring but also for the downstream clinical metrics on one public and two private cardiac ultrasound datasets containing a total of 1264 patients. Code is available at: https://github.com/ThierryJudge/contouring-uncertainty.

Transcript

Introduction to the show: ident: AI Radio. Generated commentary on the latest Artificial Intelligence papers.

Tom: Today's paper: "Uncertainty Propagation for Echocardiography Clinical Metric Estimation via Contour Sampling".

Jane: The gist: This work proposes a novel uncertainty estimation method based on contouring rather than segmentation to propagate uncertainty from input images to derived clinical metrics in echocardiography.

Tom: First, who's behind it and why it matters.

Paper summary: Tom: We've touched on the setup of this paper and what they claim about moving beyond pixel-wise uncertainty. Essentially, the thesis is that because clinical parameters like left ventricular volume rely on segmentation maps, we need a way to convert pixel-wise uncertainty into useful uncertainty for those final metrics.

Jane: They point out that since there isn't a clear path to do that with standard segmentation maps, they propose using contouring instead of segmentation as their starting point for uncertainty estimation.

Lu: Their core idea is to explicitly predict the location uncertainty of the contour points themselves. This allows them to draw samples from these predicted uncertainties, which then feed into a propagation step for clinical metrics.

Meng: So they are proposing this pipeline: Predict contour uncertainty, sample contours based on that, and then use those sampled contours to calculate volume or ejection fraction with associated uncertainty.

Jane: Exactly. They train a contouring neural network to output heatmaps that encode both the center position and the uncertainty halo of a control point. This is where they start their modeling process.

Tom: They use these heatmaps to extract mean and variance, modeling each point as a two-dimensional Gaussian distribution, leading to predictions for and <ref:2502.12713#pg2>.

Lu: Then they move to the shape uncertainty modeling part where they propose a posterior shape model based on principal component analysis. This lets them model the uncertainty of one point given the position of other points.

Jane: That PCA-based posterior shape model predicts a conditional distribution, p(ss(g)) = N(mu c, c), which helps them get richer information about how points relate to each other.

Tom: And they fuse this with the contour uncertainty using a hierarchical sampling algorithm. This involves sampling basal and apex points independently and then combining their distributions by multiplying them together, like combining a likelihood and a prior term.

Meng: That hierarchical sampling sounds like it's trying to capture complex spatial dependencies in the shape model, which is necessary because you need multiple contours for metrics like volume.

Jane: The ultimate goal of this process is uncertainty propagation to clinical metrics. They use a Monte Carlo framework where they run T a samples for aleatoric and T e samples for epistemic uncertainty.

Tom: After running those samples, they compute the mean and variance for each subset of the metric, resulting in mu m1, sigma squared m1, etc <ref:2502.12713#pg2>., which leads to the final predictive uncertainty sigma squared F = sigma squared F a + sigma squared F e <ref:2502.12713#pg2>.

Lu: So, this paper is focused on providing an intelligible way to combine aleatoric and epistemic uncertainty specifically for echocardiography clinical metrics.

Jane: It moves the field away from just pixel-wise uncertainty and toward a model that captures the shape's inherent uncertainty, which seems like a much more meaningful direction for clinical application.

Conclusion: Tom: So to wrap up on "Uncertainty Propagation for Echocardiography Clinical Metric Estimation via Contour Sampling," the authors are proposing this contour-based approach as a novel way to handle uncertainty estimation in this domain.

Jane: The key implication is that by modeling contour uncertainty and shape uncertainty, we can provide a framework that correctly propagates those uncertainties to clinical metrics, which is crucial because pixel-wise uncertainty alone falls short for these tasks.

Lu: They found this method provides optimal results in clinical metric calibration when combined with temporal consistency in the sampling process.

Meng: From a deployment standpoint, it's powerful because it addresses the variability needed for accurate calibration, even if the complexity means you have to run multiple samples during inference.

Jane: It suggests that future work will involve integrating more temporal consistency into this sampling process to see how that further refines the uncertainty estimates on moving structures.

Tom: This framework gives us a concrete way to combine aleatoric and epistemic uncertainty for things like left ventricular volume and ejection fraction, which is what matters most for clinical utility.

More episodes

← Home